Skip to main navigation Skip to search Skip to main content

Immunohistological description of nongestational ovarian choriocarcinoma in two female mice with conditional loss of Trp53 driven by the Tie2 promoter

  • V Castiglioni
  • , M Farhang Ghahremani
  • , S Goossens
  • , M De Maglie
  • , M Ardizzone
  • , J J Haigh
  • , Enrico Radaelli

Research output: Contribution to journalArticleOtherpeer-review

Abstract

Nongestational ovarian choriocarcinoma (NGCO) is a tumor of germ cell origin seldom described in nonhuman species. Few spontaneous cases are reported in macaques and mice, with the B6C3F1 strain overrepresented. This report describes 2 cases of ovarian choriocarcinoma in nulliparous female mice with conditional loss of Trp53 under the Tie2 promoter. The mouse line was maintained on a mixed genetic background including Crl: CD1(ICR) and 129X1/SvJ strains. In both cases, affected ovary was partially replaced by blood-filled lacunae lined by neoplastic trophoblast-like giant cells. Immunohistochemically, neoplastic cells expressed folate-binding protein and prolactin and were invariably negative for p53. To the authors? knowledge, this is the first report characterizing this entity in a genetically engineered mouse (GEM) line. Considering that germ cells (the cell population from which NGCO originates) constitutively express Tie2 receptor, it can be speculated that Tie2-driven deletion of Trp53 may have played a role in the development of these tumors.
Original languageEnglish
Pages (from-to)752-756
Number of pages5
JournalVeterinary Pathology
Volume52
Issue number4
DOIs
Publication statusPublished - 2015
Externally publishedYes

Keywords

  • choriocarcinoma
  • genetically engineered mouse
  • ovary
  • Trp53

Cite this